Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burton

Showing results (831-840 of 1,376) with videos related to

Pageof 138
Sort By:
The Journal of Infectious Diseases|January 4, 2008
Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infectionSusan Smyk-Pearson, Lucy Golden-Mason, Jared Klarquist, et al.
The American Journal of Cardiology|May 1, 1994
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study)V Dzavik, D S Beanlands, R F Davies, et al.
Journal of Virology|November 8, 2014
Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelopeKatie J Doores, Leopold Kong, Stefanie A Krumm, et al.
Journal of Neuroimmunology|May 20, 1998
Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitisY F Graus, J J Verschuuren, A Degenhardt, et al.
The Journal of Infectious Diseases|May 28, 2014
A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virusJennifer E Schuster, Reagan G Cox, Andrew K Hastings, et al.
Journal of the American Chemical Society|September 22, 2023
Solid-Phase Compatible Silane-Based Cleavable Linker Enables Custom Isobaric Quantitative ChemoproteomicsNikolas R Burton, Daniel A Polasky, Flowreen Shikwana, et al.
BMC Medical Ethics|April 6, 2017
The ECOUTER methodology for stakeholder engagement in translational researchMadeleine J Murtagh, Joel T Minion, Andrew Turner, et al.
Respiratory Care|July 14, 2000
Lung models: strengths and limitationsT B Martonen, C J Musante, R A Segal, et al.
Biochemical and Biophysical Research Communications|March 18, 2000
Copper has differential effect on prion protein with polymorphism of position 129B S Wong, C Clive, S J Haswell, et al.
Journal of Virology|January 1, 1995
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120J P Moore, Y Cao, L Qing, et al.
Pageof 138

Showing results (831-840 of 1,376) with videos related to

Sort By:
Pageof 138
The Journal of Infectious Diseases|January 4, 2008
Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infectionSusan Smyk-Pearson, Lucy Golden-Mason, Jared Klarquist, et al.
The American Journal of Cardiology|May 1, 1994
Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study)V Dzavik, D S Beanlands, R F Davies, et al.
Journal of Virology|November 8, 2014
Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelopeKatie J Doores, Leopold Kong, Stefanie A Krumm, et al.
Journal of Neuroimmunology|May 20, 1998
Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitisY F Graus, J J Verschuuren, A Degenhardt, et al.
The Journal of Infectious Diseases|May 28, 2014
A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virusJennifer E Schuster, Reagan G Cox, Andrew K Hastings, et al.
Journal of the American Chemical Society|September 22, 2023
Solid-Phase Compatible Silane-Based Cleavable Linker Enables Custom Isobaric Quantitative ChemoproteomicsNikolas R Burton, Daniel A Polasky, Flowreen Shikwana, et al.
BMC Medical Ethics|April 6, 2017
The ECOUTER methodology for stakeholder engagement in translational researchMadeleine J Murtagh, Joel T Minion, Andrew Turner, et al.
Respiratory Care|July 14, 2000
Lung models: strengths and limitationsT B Martonen, C J Musante, R A Segal, et al.
Biochemical and Biophysical Research Communications|March 18, 2000
Copper has differential effect on prion protein with polymorphism of position 129B S Wong, C Clive, S J Haswell, et al.
Journal of Virology|January 1, 1995
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120J P Moore, Y Cao, L Qing, et al.
Pageof 138